Global leader in medical imaging and information solutions selects clinivation to advance international market access initiatives.
NATICK, MA – March 26, 2013 – Clinivation, Inc. is pleased to announce today that INFINITT Healthcare has selected clinivation to advance certain international market access initiatives.
Ever-proliferating and changing global regulations generate complex challenges of execution in global market clearance operations.
Clinivation’s experienced Technology-Enabled CRO Services team understands how to approach and overcome complex development, quality, regulatory, and market access hurdles.
Unlike traditional consulting, Technology-Enabled CRO Services employs domain-specific information technology to achieve a high operational tempo and an operational fluidity that advances to milestones and deliverables with quality and efficiency.
Quotes & Commentary:
“We look forward working with the Infinitt teams in Korea and in the U.S. and advancing the international market access initiatives,” said clinivation Founder and CEO Joseph Kozikowski, M.D. “I thank Chief Executive Dave Smarro and his team for their leadership and support,” he continued.
For more information on the clinivation’s Technology-Enabled CRO Services, please visit the clinivation CRO Services homepage
For more information on the clinivation Enterprise Solution for Global Market Clearance Management, please visit the clinivation Global homepage.
About INFINITT Healthcare:
INFINITT Healthcare Co., Ltd. is engaged in the research, development, and distribution of medical imaging and information solutions and services worldwide.
Its product line comprises: INFINITT PACS, a Web-based image management solution; NFINITT RIS, a Web-based suite to enhance and performance for radiology staffs; NFINITT Report System, an informative reporting tool that enables the management of reports within INFINITT PACS system; and NFINITT MAMMO PACS, which is designed for the specific requirements of breast imaging and provides a comprehensive PACS solution.
The company also offers: INFINITT Mobile Viewer, a medical image viewing application that runs on mobile devices; INFINITT ULite, an HTML-5 based PACS viewing software that runs on Web browsers; Xelis, a 3D diagnosis support system; Xelis Thin Client, which realizes 3D images without any time or place; and INFINITT Vet PACS for veterinary images.
In addition, it provides INFINITT Cardiology PACS, a Web-based suite of clinical and reporting tools for cardiology, cardiovascular, and vascular imaging, as well as Xelis Cardiac tools for coronary CT angiography and left/right ventricle analysis; and INFINITT Dental, a Web-based image management solution for dentists, as well as Xelis Dental, a dental implant simulation software for dentists and implantologists.
Further, the company offers: INFINITT RT PACS, a radiation therapy image management solution for radiation oncology and INFINITT RTIS, a radiation treatment information system to support radiation treatment workflow in Korea; INFINITT Ophthalmology, an ophthalmology information solution for diagnosis and treatment in ophthalmology; Xelis 3D, Cardiac, Lung, Fusion, and Perfusion visualization solutions; and INFINITT Intensive Care Unit to provide accurate and reliable management of intensive care units’ medical records.
The company sells its products through distributors. INFINITT Healthcare Co., Ltd. is based in Seoul, South Korea.